Abstract | AIMS: Impaired anti-inflammatory ability of high-density lipoprotein (HDL) has been demonstrated in patients with type-2 diabetes mellitus (T2DM). However, whether HDL from patients with diabetic nephropathy (DN) suffers additional damage remains unknown. This study compared the anti-inflammatory capacities of HDL from healthy controls, T2DM patients with normal renal function, and T2DM patients with DN. MATERIALS AND METHODS: HDL was isolated from healthy controls (n=33) and T2DM patients with normal renal function (n=21), chronic kidney disease (CKD) (n=27), and end-stage renal disease ( ESRD) (n=27). Human peripheral blood mononuclear cells (PBMCs) from healthy volunteers were pretreated with HDL (100μg/mL) for 1h, then incubated with lipopolysaccharide (LPS) (50ng/mL) for 24h. The anti-inflammatory ability of HDL was measured as the secretion of TNF-α in LPS-activated monocytes. RESULTS: The anti-inflammatory ability of HDL was gradually impaired as kidney function declined. Serum amyloid A (SAA) concentration in HDLDN significantly increased and was positively correlated with the impaired anti-inflammatory ability of HDL (Pearson r=0.315, P=0.006). Furthermore, HDL supplemented with SAA significantly increased TNF-α release from PBMCs compared with that from control HDL. CONCLUSIONS: These findings identified an impaired anti-inflammatory capacity of HDL from DN patients, which might be attributable to SAA enrichment.
|
Authors | Jing Yan Mao, Jia Teng Sun, Ke Yang, Wei Feng Shen, Lin Lu, Rui Yan Zhang, Xuemei Tong, Yan Liu |
Journal | Journal of diabetes and its complications
(J Diabetes Complications)
Vol. 31
Issue 10
Pg. 1538-1543
(Oct 2017)
ISSN: 1873-460X [Electronic] United States |
PMID | 28760652
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 Elsevier Inc. All rights reserved. |
Chemical References |
- Lipopolysaccharides
- Lipoproteins, HDL
- Serum Amyloid A Protein
|
Topics |
- Adult
- Aged
- Cells, Cultured
- China
(epidemiology)
- Cross-Sectional Studies
- Diabetes Mellitus, Type 2
(complications)
- Diabetic Angiopathies
(epidemiology, immunology, metabolism, pathology)
- Diabetic Nephropathies
(immunology, metabolism, pathology, physiopathology)
- Female
- Hospitals, University
- Humans
- Kidney
(physiopathology)
- Kidney Failure, Chronic
(complications, immunology, metabolism, pathology)
- Leukocytes, Mononuclear
(drug effects, immunology, metabolism, pathology)
- Lipopolysaccharides
(toxicity)
- Lipoproteins, HDL
(blood, isolation & purification, metabolism)
- Male
- Middle Aged
- Outpatient Clinics, Hospital
- Renal Insufficiency, Chronic
(complications, immunology, metabolism, pathology)
- Risk Factors
- Serum Amyloid A Protein
(analysis, metabolism)
- Severity of Illness Index
- Vasculitis
(complications, immunology, metabolism, pathology)
|